Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Daniel Weiss ’85, former president and CEO of the Metropolitan Museum of Art, discusses the distinctive joys and challenges ...
According to Prof. Jeffrey Sonnenfeld and co-author Steven Tian, the college and university presidents who attended the Yale ...
Howie and Harlan discuss a breakthrough pain medication, studies on AI-assisted medicine, the explosion of sports gambling, and the health consequences of the shutdown of USAID. Links: A ...
Daniel Weiss ’85, former president and CEO of the Metropolitan Museum of Art, discusses the distinctive joys and challenges of leading mission-driven organizations.‌ ...